230 related articles for article (PubMed ID: 36223668)
1. Clinical relevance of single-subject brain metabolism patterns in amyotrophic lateral sclerosis mutation carriers.
Tondo G; Mazzini L; Caminiti SP; Sarnelli MF; Corrado L; Matheoud R; D'Alfonso S; Cantello R; Sacchetti GM; Perani D; Comi C; De Marchi F
Neuroimage Clin; 2022; 36():103222. PubMed ID: 36223668
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneous brain FDG-PET metabolic patterns in patients with C9orf72 mutation.
Castelnovo V; Caminiti SP; Riva N; Magnani G; Silani V; Perani D
Neurol Sci; 2019 Mar; 40(3):515-521. PubMed ID: 30554355
[TBL] [Abstract][Full Text] [Related]
3. Value of 18fluorodeoxyglucose-positron-emission tomography in amyotrophic lateral sclerosis: a prospective study.
Van Laere K; Vanhee A; Verschueren J; De Coster L; Driesen A; Dupont P; Robberecht W; Van Damme P
JAMA Neurol; 2014 May; 71(5):553-61. PubMed ID: 24615479
[TBL] [Abstract][Full Text] [Related]
4. Multicenter validation of [
D'hulst L; Van Weehaeghe D; Chiò A; Calvo A; Moglia C; Canosa A; Cistaro A; Willekens SM; De Vocht J; Van Damme P; Pagani M; Van Laere K
Amyotroph Lateral Scler Frontotemporal Degener; 2018 Nov; 19(7-8):570-577. PubMed ID: 29862846
[TBL] [Abstract][Full Text] [Related]
5. Testing the diagnostic accuracy of [18F]FDG-PET in discriminating spinal- and bulbar-onset amyotrophic lateral sclerosis.
Sala A; Iaccarino L; Fania P; Vanoli EG; Fallanca F; Pagnini C; Cerami C; Calvo A; Canosa A; Pagani M; Chiò A; Cistaro A; Perani D
Eur J Nucl Med Mol Imaging; 2019 May; 46(5):1117-1131. PubMed ID: 30617963
[TBL] [Abstract][Full Text] [Related]
6. Amyotrophic lateral sclerosis with SOD1 mutations shows distinct brain metabolic changes.
Canosa A; Calvo A; Moglia C; Vasta R; Palumbo F; Solero L; Di Pede F; Cabras S; Arena V; Zocco G; Casale F; Brunetti M; Sbaiz L; Gallone S; Grassano M; Manera U; Pagani M; Chiò A
Eur J Nucl Med Mol Imaging; 2022 Jun; 49(7):2242-2250. PubMed ID: 35076740
[TBL] [Abstract][Full Text] [Related]
7. The metabolic signature of C9ORF72-related ALS: FDG PET comparison with nonmutated patients.
Cistaro A; Pagani M; Montuschi A; Calvo A; Moglia C; Canosa A; Restagno G; Brunetti M; Traynor BJ; Nobili F; Carrara G; Fania P; Lopiano L; Valentini MC; Chiò A
Eur J Nucl Med Mol Imaging; 2014 May; 41(5):844-52. PubMed ID: 24445987
[TBL] [Abstract][Full Text] [Related]
8. Prospective Validation of 18F-FDG Brain PET Discriminant Analysis Methods in the Diagnosis of Amyotrophic Lateral Sclerosis.
Van Weehaeghe D; Ceccarini J; Delva A; Robberecht W; Van Damme P; Van Laere K
J Nucl Med; 2016 Aug; 57(8):1238-43. PubMed ID: 26940764
[TBL] [Abstract][Full Text] [Related]
9. Differences in Cerebral Glucose Metabolism in ALS Patients with and without
De Vocht J; Van Weehaeghe D; Ombelet F; Masrori P; Lamaire N; Devrome M; Van Esch H; Moisse M; Koole M; Dupont P; Van Laere K; Van Damme P
Cells; 2023 Mar; 12(6):. PubMed ID: 36980274
[TBL] [Abstract][Full Text] [Related]
10. Amyloid- and FDG-PET imaging in amyotrophic lateral sclerosis.
Matías-Guiu JA; Pytel V; Cabrera-Martín MN; Galán L; Valles-Salgado M; Guerrero A; Moreno-Ramos T; Matías-Guiu J; Carreras JL
Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):2050-60. PubMed ID: 27262702
[TBL] [Abstract][Full Text] [Related]
11. Brain FDG-PET changes in ALS and ALS-FTD.
Renard D; Collombier L; Castelnovo G; Fourcade G; Kotzki PO; LaBauge P
Acta Neurol Belg; 2011 Dec; 111(4):306-9. PubMed ID: 22368970
[TBL] [Abstract][Full Text] [Related]
12. FDG-PET shows weak correlation between focal motor weakness and brain metabolic alterations in ALS.
Sennfält S; Pagani M; Fang F; Savitcheva I; Estenberg U; Ingre C
Amyotroph Lateral Scler Frontotemporal Degener; 2023 Aug; 24(5-6):485-494. PubMed ID: 36755485
[No Abstract] [Full Text] [Related]
13. Functional pattern of brain FDG-PET in amyotrophic lateral sclerosis.
Pagani M; Chiò A; Valentini MC; Öberg J; Nobili F; Calvo A; Moglia C; Bertuzzo D; Morbelli S; De Carli F; Fania P; Cistaro A
Neurology; 2014 Sep; 83(12):1067-74. PubMed ID: 25122207
[TBL] [Abstract][Full Text] [Related]
14. Comparison of univariate and multivariate analyses for brain [18F]FDG PET data in α-synucleinopathies.
Carli G; Meles SK; Reesink FE; de Jong BM; Pilotto A; Padovani A; Galbiati A; Ferini-Strambi L; Leenders KL; Perani D
Neuroimage Clin; 2023; 39():103475. PubMed ID: 37494757
[TBL] [Abstract][Full Text] [Related]
15. 18F-FDG-PET correlates of cognitive impairment in ALS.
Canosa A; Pagani M; Cistaro A; Montuschi A; Iazzolino B; Fania P; Cammarosano S; Ilardi A; Moglia C; Calvo A; Chiò A
Neurology; 2016 Jan; 86(1):44-9. PubMed ID: 26590270
[TBL] [Abstract][Full Text] [Related]
16. Voxel-based mapping of grey matter volume and glucose metabolism profiles in amyotrophic lateral sclerosis.
Buhour MS; Doidy F; Mondou A; Pélerin A; Carluer L; Eustache F; Viader F; Desgranges B
EJNMMI Res; 2017 Dec; 7(1):21. PubMed ID: 28266002
[TBL] [Abstract][Full Text] [Related]
17. Coupling motor evoked potentials and BRAIN [
Tondo G; Mazzini L; Caminiti SP; Gallo C; Matheoud R; Comi C; Sacchetti GM; Perani D; De Marchi F
Neurobiol Dis; 2024 Jun; ():106579. PubMed ID: 38936435
[TBL] [Abstract][Full Text] [Related]
18. Different FDG-PET metabolic patterns at single-subject level in the behavioral variant of fronto-temporal dementia.
Cerami C; Dodich A; Lettieri G; Iannaccone S; Magnani G; Marcone A; Gianolli L; Cappa SF; Perani D
Cortex; 2016 Oct; 83():101-12. PubMed ID: 27498041
[TBL] [Abstract][Full Text] [Related]
19. Brain metabolic signatures in patients with genetic and nongenetic amyotrophic lateral sclerosis.
Liu P; Tang Y; Li W; Liu Z; Zhou M; Li J; Yuan Y; Fang L; Guo J; Shen L; Jiang H; Tang B; Hu S; Wang J
CNS Neurosci Ther; 2023 Sep; 29(9):2530-2539. PubMed ID: 36971206
[TBL] [Abstract][Full Text] [Related]
20. Brain metabolic correlates of apathy in amyotrophic lateral sclerosis: An 18F-FDG-positron emission tomography stud.
Canosa A; Vacchiano V; D'Ovidio F; Calvo A; Moglia C; Manera U; Vasta R; Liguori R; Arena V; Grassano M; Palumbo F; Peotta L; Iazzolino B; Pagani M; Chiò A
Eur J Neurol; 2021 Mar; 28(3):745-753. PubMed ID: 33175462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
